SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-257589
Filing Date
2022-10-04
Accepted
2022-10-04 16:07:24
Documents
15
Period of Report
2022-09-30
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d397743d8k.htm   iXBRL 8-K 62296
2 EX-4.1 d397743dex41.htm EX-4.1 938344
3 EX-4.2 d397743dex42.htm EX-4.2 971227
4 EX-4.3 d397743dex43.htm EX-4.3 626230
  Complete submission text file 0001193125-22-257589.txt   3293573

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA bhc-20220930.xsd EX-101.SCH 2534
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE bhc-20220930_lab.xml EX-101.LAB 18798
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bhc-20220930_pre.xml EX-101.PRE 11779
9 EXTRACTED XBRL INSTANCE DOCUMENT d397743d8k_htm.xml XML 3498
Mailing Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8
Business Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8 514-744-6792
Bausch Health Companies Inc. (Filer) CIK: 0000885590 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14956 | Film No.: 221291548
SIC: 2834 Pharmaceutical Preparations